HOME > Takeda’s £46 Billion Shire Buyout
Takeda’s £46 Billion Shire Buyout
-
Takeda Completes £46 Billion Shire Acquisition
January 8, 2019
-
After Thumbs-Up Given to Shire Buy, Weber’s Leadership Will Now Be Put to Test
December 12, 2018
-
Shareholders Give Blessing to £46 Billion Shire Pact as Weber Touts US Foothold
December 6, 2018
-
Takeda Shareholders OK £46 Billion Shire Takeover
December 5, 2018
-
Takeda Family Member Comes Forward for Final Appeal to Veto Shire Deal, but Admits Uphill Battle
December 4, 2018
-
Takeda Inks US$3.7 Billion Loan Accord with JBIC
December 4, 2018
-
Dissident Shareholder Group Hails Ex-Takeda Chief’s Opposition to Shire Deal
November 29, 2018
-
Dissident Takeda Shareholders Making Final Pitch to Thwart Shire Buyout
November 26, 2018
-
Takeda Gets European OK for Shire Deal with Strings Attached
November 21, 2018
-
Takeda to Issue US$5.5 Billion in Bonds for Shire Acquisition
November 21, 2018
-
Takeda to Procure €7.5 Billion in Bonds for Shire Acquisition
November 19, 2018
-
Big Takeda Could Debut as Early as January 8, De-facto Vote on Shire Deal Set for Dec. 5
November 13, 2018
-
Takeda Unveils Estimated Net Debt, Goodwill Post Shire Integration
November 2, 2018
-
Takeda Unveils Post-Acquisition Executive Team, 2 of 20 Members from Shire
November 1, 2018
-
Takeda Mulls Sale of Shire GI Pipeline to Clinch European Clearance
October 29, 2018
-
Takeda Earns Japan Clearance for Shire Acquisition
October 19, 2018
-
Takeda Alumni Shareholders Send Open Letter Questioning Shire Buyout
October 9, 2018
-
Takeda Gets China OK for Shire Takeover
September 18, 2018
-
Takeda Integration Team Prepping for Shire Takeover: Weber
August 1, 2018
-
Takeda Clinches Key US Clearance for Shire Takeover
July 10, 2018
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
